| Year |
Citation |
Score |
| 2020 |
Lanfranco MF, Ng CA, Rebeck GW. ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease. International Journal of Molecular Sciences. 21. PMID 32882843 DOI: 10.3390/ijms21176336 |
0.437 |
|
| 2020 |
Demby TC, Rodriguez O, McCarthy CW, Lee YC, Albanese C, Mandelblatt J, Rebeck GW. A Mouse Model of Chemotherapy-Related Cognitive Impairments Integrating the Risk Factors of Aging and APOE4 Genotype. Behavioural Brain Research. 112534. PMID 32027870 DOI: 10.1016/J.Bbr.2020.112534 |
0.378 |
|
| 2020 |
Flowers SA, Rebeck GW. APOE in the normal brain. Neurobiology of Disease. 136: 104724. PMID 31911114 DOI: 10.1016/J.Nbd.2019.104724 |
0.466 |
|
| 2019 |
Flowers SA, Grant OC, Woods RJ, Rebeck GW. O-glycosylation on cerebrospinal fluid and plasma Apolipoprotein E differs in the lipid binding domain. Glycobiology. PMID 31616924 DOI: 10.1093/Glycob/Cwz084 |
0.35 |
|
| 2018 |
Chernick D, Ortiz-Valle S, Jeong A, Swaminathan SK, Kandimalla K, Rebeck GW, Li L. HDL Mimetic Peptide 4F Mitigates Aβ-Induced Inhibition of ApoE Secretion and Lipidation in Primary Astrocytes and Microglia. Journal of Neurochemistry. PMID 30028014 DOI: 10.1111/Jnc.14554 |
0.437 |
|
| 2018 |
Jacobs J, Shattuck K, Ashburn S, Horton W, DiBattista AM, Rebeck GW, Howard JH, Turner RS, Jiang X. P2-495: Behavioral And Mri Measures Show Impaired Spatial Inhibition Of Return In Mild Cognitive Impairment And Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1188 |
0.754 |
|
| 2017 |
Rebeck GW. The role of APOE on lipid homeostasis and inflammation in normal brains. Journal of Lipid Research. 58: 1493-1499. PMID 28258087 DOI: 10.1194/jlr.R075408 |
0.344 |
|
| 2016 |
Heinsinger NM, Gachechiladze MA, Rebeck GW. Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid. Journal of Neuropathology and Experimental Neurology. 75: 918-924. PMID 27516118 DOI: 10.1093/Jnen/Nlw067 |
0.794 |
|
| 2016 |
DiBattista AM, Dumanis SB, Newman J, Rebeck GW. Identification and modification of amyloid-independent phenotypes of APOE4 mice. Experimental Neurology. PMID 27085394 DOI: 10.1016/J.Expneurol.2016.04.014 |
0.796 |
|
| 2016 |
Lussier AL, Weeber EJ, Rebeck GW. Reelin Proteolysis Affects Signaling Related to Normal Synapse Function and Neurodegeneration. Frontiers in Cellular Neuroscience. 10: 75. PMID 27065802 DOI: 10.3389/fncel.2016.00075 |
0.355 |
|
| 2015 |
Malik M, Parikh I, Vasquez JB, Smith C, Tai L, Bu G, LaDu MJ, Fardo DW, Rebeck GW, Estus S. Genetics ignite focus on microglial inflammation in Alzheimer's disease. Molecular Neurodegeneration. 10: 52. PMID 26438529 DOI: 10.1186/S13024-015-0048-1 |
0.393 |
|
| 2015 |
Zhou Y, Zhao W, Al-Muhtasib N, Rebeck GW. APOE Genotype Alters Immunoglobulin Subtypes in Knock-In Mice. Journal of Alzheimer's Disease : Jad. 46: 365-74. PMID 25737044 DOI: 10.3233/JAD-142184 |
0.417 |
|
| 2015 |
DiBattista AM, Dumanis SB, Rebeck GW. O3-06-05: Apolipoprotein e-associated brain biomarkers in mice are rescued by ibuprofen Alzheimer's & Dementia. 11: P231-P232. DOI: 10.1016/J.Jalz.2015.07.271 |
0.77 |
|
| 2015 |
Kreisl WC, Lyoo CH, Wei M, Snow J, Jenko KJ, Morse CL, Zoghbi SS, Liow J, DiBattista AM, Rebeck GW, Pike VW, Turner RS, Innis RB. Increased radioligand binding to translocator protein correlates with worsened clinical severity and atrophy in Alzheimer's disease Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.111 |
0.771 |
|
| 2014 |
Burrell TC, Divekar SD, Weeber EJ, Rebeck GW. Fyn tyrosine kinase increases Apolipoprotein E Receptor 2 levels and phosphorylation. Plos One. 9: e110845. PMID 25340851 DOI: 10.1371/journal.pone.0110845 |
0.341 |
|
| 2014 |
DiBattista AM, Stevens BW, Rebeck GW, Green AE. Two Alzheimer's disease risk genes increase entorhinal cortex volume in young adults. Frontiers in Human Neuroscience. 8: 779. PMID 25339884 DOI: 10.3389/Fnhum.2014.00779 |
0.792 |
|
| 2014 |
Zhao W, Zhang J, Davis EG, Rebeck GW. Aging reduces glial uptake and promotes extracellular accumulation of Aβ from a lentiviral vector. Frontiers in Aging Neuroscience. 6: 210. PMID 25177293 DOI: 10.3389/fnagi.2014.00210 |
0.432 |
|
| 2014 |
Rodriguez GA, Tai LM, LaDu MJ, Rebeck GW. Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition. Journal of Neuroinflammation. 11: 111. PMID 24948358 DOI: 10.1186/1742-2094-11-111 |
0.703 |
|
| 2014 |
Tamboli IY, Heo D, Rebeck GW. Extracellular proteolysis of apolipoprotein E (apoE) by secreted serine neuronal protease. Plos One. 9: e93120. PMID 24675880 DOI: 10.1371/journal.pone.0093120 |
0.395 |
|
| 2014 |
Tai LM, Mehra S, Shete V, Estus S, Rebeck GW, Bu G, LaDu MJ. Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk. Molecular Neurodegeneration. 9: 2. PMID 24386905 DOI: 10.1186/1750-1326-9-2 |
0.464 |
|
| 2014 |
Nwabuisi-Heath E, Rebeck GW, Ladu MJ, Yu C. ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro. Asn Neuro. 6: e00134. PMID 24328732 DOI: 10.1042/AN20130043 |
0.421 |
|
| 2013 |
Nelson PT, Pious NM, Jicha GA, Wilcock DM, Fardo DW, Estus S, Rebeck GW. APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature. Journal of Neuropathology and Experimental Neurology. 72: 708-15. PMID 23771217 DOI: 10.1097/Nen.0B013E31829A25B9 |
0.426 |
|
| 2013 |
Rodriguez GA, Burns MP, Weeber EJ, Rebeck GW. Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex. Learning & Memory (Cold Spring Harbor, N.Y.). 20: 256-66. PMID 23592036 DOI: 10.1101/Lm.030031.112 |
0.666 |
|
| 2013 |
Dumanis SB, DiBattista AM, Miessau M, Moussa CE, Rebeck GW. APOE genotype affects the pre-synaptic compartment of glutamatergic nerve terminals. Journal of Neurochemistry. 124: 4-14. PMID 22862561 DOI: 10.1111/J.1471-4159.2012.07908.X |
0.796 |
|
| 2013 |
Manaye KF, Mouton PR, Xu G, Drew A, Lei DL, Sharma Y, Rebeck GW, Turner S. Age-related loss of noradrenergic neurons in the brains of triple transgenic mice Age. 35: 139-147. PMID 22127507 DOI: 10.1007/S11357-011-9343-0 |
0.411 |
|
| 2012 |
Youmans KL, Tai LM, Nwabuisi-Heath E, Jungbauer L, Kanekiyo T, Gan M, Kim J, Eimer WA, Estus S, Rebeck GW, Weeber EJ, Bu G, Yu C, Ladu MJ. APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease. The Journal of Biological Chemistry. 287: 41774-86. PMID 23060451 DOI: 10.1074/Jbc.M112.407957 |
0.47 |
|
| 2012 |
Dumanis SB, Chamberlain KA, Jin Sohn Y, Jin Lee Y, Guénette SY, Suzuki T, Mathews PM, Pak DTs, Rebeck GW, Suh YH, Park HS, Hoe HS. FE65 as a link between VLDLR and APP to regulate their trafficking and processing. Molecular Neurodegeneration. 7: 9. PMID 22429478 DOI: 10.1186/1750-1326-7-9 |
0.684 |
|
| 2012 |
Herman AM, Khandelwal PJ, Rebeck GW, Moussa CE. Wild type TDP-43 induces neuro-inflammation and alters APP metabolism in lentiviral gene transfer models. Experimental Neurology. 235: 297-305. PMID 22402344 DOI: 10.1016/j.expneurol.2012.02.011 |
0.445 |
|
| 2012 |
Zhu Y, Nwabuisi-Heath E, Dumanis SB, Tai LM, Yu C, Rebeck GW, LaDu MJ. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia. 60: 559-69. PMID 22228589 DOI: 10.1002/Glia.22289 |
0.745 |
|
| 2012 |
Khandelwal PJ, Dumanis SB, Herman AM, Rebeck GW, Moussa CE. Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models. Molecular and Cellular Neurosciences. 49: 44-53. PMID 21945393 DOI: 10.1016/J.Mcn.2011.09.002 |
0.721 |
|
| 2012 |
Minami SS, Clifford TG, Hoe HS, Matsuoka Y, Rebeck GW. Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3×Tg-AD mice. Neurobiology of Aging. 33: 825.e15-24. PMID 21741124 DOI: 10.1016/j.neurobiolaging.2011.05.014 |
0.77 |
|
| 2011 |
Babus LW, Little EM, Keenoy KE, Minami SS, Chen E, Song JM, Caviness J, Koo SY, Pak DT, Rebeck GW, Turner RS, Hoe HS. Decreased dendritic spine density and abnormal spine morphology in Fyn knockout mice. Brain Research. 1415: 96-102. PMID 21872217 DOI: 10.1016/j.brainres.2011.07.059 |
0.727 |
|
| 2011 |
Rogers JT, Rusiana I, Trotter J, Zhao L, Donaldson E, Pak DT, Babus LW, Peters M, Banko JL, Chavis P, Rebeck GW, Hoe HS, Weeber EJ. Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density. Learning & Memory (Cold Spring Harbor, N.Y.). 18: 558-64. PMID 21852430 DOI: 10.1101/Lm.2153511 |
0.324 |
|
| 2011 |
Minami SS, Hoe HS, Rebeck GW. Fyn kinase regulates the association between amyloid precursor protein and Dab1 by promoting their localization to detergent-resistant membranes Journal of Neurochemistry. 118: 879-890. PMID 21534960 DOI: 10.1111/j.1471-4159.2011.07296.x |
0.753 |
|
| 2011 |
Khandelwal PJ, Herman AM, Hoe HS, Rebeck GW, Moussa CE. Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated Abeta in AD models. Human Molecular Genetics. 20: 2091-102. PMID 21378096 DOI: 10.1093/hmg/ddr091 |
0.435 |
|
| 2011 |
Herman AM, Khandelwal PJ, Stanczyk BB, Rebeck GW, Moussa CE. β-amyloid triggers ALS-associated TDP-43 pathology in AD models. Brain Research. 1386: 191-9. PMID 21376022 DOI: 10.1016/j.brainres.2011.02.052 |
0.452 |
|
| 2011 |
Dumanis SB, Cha HJ, Song JM, Trotter JH, Spitzer M, Lee JY, Weeber EJ, Turner RS, Pak DT, Rebeck GW, Hoe HS. ApoE receptor 2 regulates synapse and dendritic spine formation. Plos One. 6: e17203. PMID 21347244 DOI: 10.1371/Journal.Pone.0017203 |
0.678 |
|
| 2011 |
Loane DJ, Washington PM, Vardanian L, Pocivavsek A, Hoe HS, Duff KE, Cernak I, Rebeck GW, Faden AI, Burns MP. Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury. Journal of Neurotrauma. 28: 225-36. PMID 21175399 DOI: 10.1089/Neu.2010.1595 |
0.745 |
|
| 2011 |
Khandelwal P, Herman A, Rebeck GW, Moussa C. P2-486: Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated Abeta in alzheimer's DISEASE models Alzheimer's & Dementia. 7: S468-S468. DOI: 10.1016/j.jalz.2011.05.1357 |
0.375 |
|
| 2010 |
Khandelwal PJ, Dumanis SB, Feng LR, Maguire-Zeiss K, Rebeck G, Lashuel HA, Moussa CE. Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model. Molecular Neurodegeneration. 5: 47. PMID 21050448 DOI: 10.1186/1750-1326-5-47 |
0.679 |
|
| 2010 |
Minami SS, Sidahmed E, Aid S, Shimoji M, Niikura T, Mocchetti I, Rebeck GW, Prendergast JS, Dealwis C, Wetzel R, Bosetti F, Matsuoka Y, Hoe HS, Turner RS. Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease. Journal of Neuroinflammation. 7: 57. PMID 20920207 DOI: 10.1186/1742-2094-7-57 |
0.767 |
|
| 2010 |
Minami SS, Cordova A, Cirrito JR, Tesoriero JA, Babus LW, Davis GC, Dakshanamurthy S, Turner RS, Pak DTs, Rebeck GW, Paige M, Hoe HS. ApoE mimetic peptide decreases Abeta production in vitro and in vivo. Molecular Neurodegeneration. 5: 16. PMID 20406479 DOI: 10.1186/1750-1326-5-16 |
0.763 |
|
| 2010 |
Burns MP, Rebeck GW. Intracellular cholesterol homeostasis and amyloid precursor protein processing. Biochimica Et Biophysica Acta. 1801: 853-9. PMID 20304094 DOI: 10.1016/J.Bbalip.2010.03.004 |
0.388 |
|
| 2010 |
Tomidokoro Y, Rostagno A, Neubert TA, Lu Y, Rebeck GW, Frangione B, Greenberg SM, Ghiso J. Iowa variant of familial Alzheimer's disease: accumulation of posttranslationally modified AbetaD23N in parenchymal and cerebrovascular amyloid deposits. The American Journal of Pathology. 176: 1841-54. PMID 20228223 DOI: 10.2353/Ajpath.2010.090636 |
0.42 |
|
| 2010 |
Rebeck GW, Hoe HS, Moussa CEH. β-Amyloid1-42 gene transfer model exhibits intraneuronal amyloid, gliosis, tau phosphorylation, and neuronal loss Journal of Biological Chemistry. 285: 7440-7446. PMID 20071340 DOI: 10.1074/jbc.M109.083915 |
0.42 |
|
| 2010 |
Cartagena CM, Burns MP, Rebeck GW. 24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury. Brain Research. 1319: 1-12. PMID 20053345 DOI: 10.1016/J.Brainres.2009.12.080 |
0.762 |
|
| 2010 |
Minami SS, Sung YM, Dumanis SB, Chi SH, Burns MP, Ann EJ, Suzuki T, Turner RS, Park HS, Pak DT, Rebeck GW, Hoe HS. The cytoplasmic adaptor protein X11alpha and extracellular matrix protein Reelin regulate ApoE receptor 2 trafficking and cell movement. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 58-69. PMID 19720620 DOI: 10.1096/Fj.09-138123 |
0.763 |
|
| 2009 |
Dumanis SB, Tesoriero JA, Babus LW, Nguyen MT, Trotter JH, Ladu MJ, Weeber EJ, Turner RS, Xu B, Rebeck GW, Hoe HS. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 15317-22. PMID 19955384 DOI: 10.1523/Jneurosci.4026-09.2009 |
0.76 |
|
| 2009 |
Pocivavsek A, Rebeck GW. Inhibition of c-Jun N-terminal kinase increases apoE expression in vitro and in vivo. Biochemical and Biophysical Research Communications. 387: 516-20. PMID 19615334 DOI: 10.1016/j.bbrc.2009.07.048 |
0.717 |
|
| 2009 |
Pocivavsek A, Mikhailenko I, Strickland DK, Rebeck GW. Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation. Journal of Neuroimmunology. 214: 25-32. PMID 19586665 DOI: 10.1016/J.Jneuroim.2009.06.010 |
0.703 |
|
| 2009 |
Hoe HS, Lee KJ, Carney RS, Lee J, Markova A, Lee JY, Howell BW, Hyman BT, Pak DT, Bu G, Rebeck GW. Interaction of reelin with amyloid precursor protein promotes neurite outgrowth. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 7459-73. PMID 19515914 DOI: 10.1523/Jneurosci.4872-08.2009 |
0.497 |
|
| 2009 |
Burns MP, Zhang L, Rebeck GW, Querfurth HW, Moussa CE. Parkin promotes intracellular Abeta1-42 clearance. Human Molecular Genetics. 18: 3206-16. PMID 19483198 DOI: 10.1093/Hmg/Ddp258 |
0.407 |
|
| 2009 |
Loane DJ, Pocivavsek A, Moussa CE, Thompson R, Matsuoka Y, Faden AI, Rebeck GW, Burns MP. Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nature Medicine. 15: 377-9. PMID 19287391 DOI: 10.1038/Nm.1940 |
0.714 |
|
| 2009 |
Hoe HS, Fu Z, Makarova A, Lee JY, Lu C, Feng L, Pajoohesh-Ganji A, Matsuoka Y, Hyman BT, Ehlers MD, Vicini S, Pak DT, Rebeck GW. The effects of amyloid precursor protein on postsynaptic composition and activity. The Journal of Biological Chemistry. 284: 8495-506. PMID 19164281 DOI: 10.1074/Jbc.M900141200 |
0.544 |
|
| 2009 |
Hirata-Fukae C, Li HF, Ma L, Hoe HS, Rebeck GW, Aisen PS, Matsuoka Y. Levels of soluble and insoluble tau reflect overall status of tau phosphorylation in vivo Neuroscience Letters. 450: 51-55. PMID 19022346 DOI: 10.1016/J.Neulet.2008.11.023 |
0.39 |
|
| 2009 |
Pocivavsek A, Burns MP, Rebeck GW. Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase. Glia. 57: 444-53. PMID 18803301 DOI: 10.1002/Glia.20772 |
0.693 |
|
| 2009 |
Tractenberg RE, Aisen PS, Hancock GR, Rebeck GW. No cross-sectional influence of APOE epsilon4 dose on clinical tests in Alzheimer's disease. Neurobiology of Aging. 30: 1327-8. PMID 18083276 DOI: 10.1016/J.Neurobiolaging.2007.11.006 |
0.387 |
|
| 2009 |
Loane DJ, Matsuoka Y, Rebeck GW, Faden AI, Burns MP. Abstract #3: APP Secretases As Therapeutic Targets for Traumatic Brain Injury Neurotherapeutics. 6: 604-605. DOI: 10.1016/J.Nurt.2009.03.004 |
0.398 |
|
| 2009 |
Minami SS, Hoe HS, Burns MP, Matsuoka Y, Rebeck GW. P4-216: Fyn kinase regulates phosphorylation and localization of APP and Dab1 to lipid rafts Alzheimer's & Dementia. 5: P494-P494. DOI: 10.1016/J.Jalz.2009.04.682 |
0.711 |
|
| 2008 |
Zhao X, Rebeck GW, Hoe HS, Andrews PM. Tarenflurbil protection from cytotoxicity is associated with an upregulation of neurotrophins Journal of Alzheimer's Disease. 15: 397-407. PMID 18997293 DOI: 10.3233/Jad-2008-15306 |
0.403 |
|
| 2008 |
Cartagena CM, Ahmed F, Burns MP, Pajoohesh-Ganji A, Pak DT, Faden AI, Rebeck GW. Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain. Journal of Neurotrauma. 25: 1087-98. PMID 18729719 DOI: 10.1089/Neu.2007.0444 |
0.773 |
|
| 2008 |
Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, Rebeck GW, LaFerla FM, Mattson MP, Iwata N, et al. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Research. 1216: 92-103. PMID 18486110 DOI: 10.1016/J.Brainres.2008.03.079 |
0.801 |
|
| 2008 |
Hoe HS, Rebeck GW. Regulated proteolysis of APP and ApoE receptors Molecular Neurobiology. 37: 64-72. PMID 18415033 DOI: 10.1007/s12035-008-8017-0 |
0.401 |
|
| 2008 |
Hoe HS, Minami SS, Makarova A, Lee J, Hyman BT, Matsuoka Y, Rebeck GW. Fyn modulation of Dab1 effects on amyloid precursor protein and ApoE receptor 2 processing. The Journal of Biological Chemistry. 283: 6288-99. PMID 18089558 DOI: 10.1074/Jbc.M704140200 |
0.778 |
|
| 2008 |
Rebeck GW. S3-02-02: Role of APOE receptors in cell signaling Alzheimer's & Dementia. 4: T151-T151. DOI: 10.1016/j.jalz.2008.05.379 |
0.305 |
|
| 2007 |
Hoe HS, Cooper MJ, Burns MP, Lewis PA, van der Brug M, Chakraborty G, Cartagena CM, Pak DT, Cookson MR, Rebeck GW. The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 10895-905. PMID 17913923 DOI: 10.1523/Jneurosci.3135-07.2007 |
0.815 |
|
| 2007 |
Eckert GP, Vardanian L, Rebeck GW, Burns MP. Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317. Neuroscience Letters. 423: 47-52. PMID 17662526 DOI: 10.1016/J.Neulet.2007.05.063 |
0.354 |
|
| 2007 |
Czech C, Burns MP, Vardanian L, Augustin A, Jacobsen H, Baumann K, Rebeck GW. Cholesterol independent effect of LXR agonist TO-901317 on gamma-secretase. Journal of Neurochemistry. 101: 929-36. PMID 17472585 DOI: 10.1111/J.1471-4159.2007.04467.X |
0.308 |
|
| 2006 |
Hoe HS, Freeman J, Rebeck GW. Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons. Molecular Neurodegeneration. 1: 18. PMID 17166269 DOI: 10.1186/1750-1326-1-18 |
0.435 |
|
| 2006 |
Rebeck GW, LaDu MJ, Estus S, Bu G, Weeber EJ. The generation and function of soluble apoE receptors in the CNS. Molecular Neurodegeneration. 1: 15. PMID 17062143 DOI: 10.1186/1750-1326-1-15 |
0.436 |
|
| 2006 |
Hoe HS, Tran TS, Matsuoka Y, Howell BW, Rebeck GW. DAB1 and reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing Journal of Biological Chemistry. 281: 35176-35185. PMID 16951405 DOI: 10.1074/Jbc.M602162200 |
0.416 |
|
| 2006 |
Hoe HS, Pocivavsek A, Dai H, Chakraborty G, Harris DC, Rebeck GW. Effects of apoE on neuronal signaling and APP processing in rodent brain. Brain Research. 1112: 70-9. PMID 16905123 DOI: 10.1016/j.brainres.2006.07.035 |
0.707 |
|
| 2006 |
Burns MP, Vardanian L, Pajoohesh-Ganji A, Wang L, Cooper M, Harris DC, Duff K, Rebeck GW. The effects of ABCA1 on cholesterol efflux and Abeta levels in vitro and in vivo. Journal of Neurochemistry. 98: 792-800. PMID 16771834 DOI: 10.1111/J.1471-4159.2006.03925.X |
0.596 |
|
| 2006 |
Hoe HS, Magill LA, Guenette S, Fu Z, Vicini S, Rebeck GW. FE65 interaction with the ApoE receptor ApoEr2. The Journal of Biological Chemistry. 281: 24521-30. PMID 16638748 DOI: 10.1074/Jbc.M600728200 |
0.313 |
|
| 2006 |
Robbins EM, Betensky RA, Domnitz SB, Purcell SM, Garcia-Alloza M, Greenberg C, Rebeck GW, Hyman BT, Greenberg SM, Frosch MP, Bacskai BJ. Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 365-71. PMID 16407531 DOI: 10.1523/Jneurosci.3854-05.2006 |
0.514 |
|
| 2006 |
Hoe HS, Pocivavsek A, Chakraborty G, Fu Z, Vicini S, Ehlers MD, Rebeck GW. Apolipoprotein E receptor 2 interactions with the N-methyl-D-aspartate receptor. The Journal of Biological Chemistry. 281: 3425-31. PMID 16332682 DOI: 10.1074/Jbc.M509380200 |
0.669 |
|
| 2006 |
Burns MP, Cernak I, Vardanian L, Cruz MI, Cartagena C, Wang L, Duff K, Rebeck GW. O4-01-04: Traumatic brain injury-a model for cholesterol redistribution and A-beta metabolism Alzheimer's & Dementia. 2: S75-S75. DOI: 10.1016/J.Jalz.2006.05.294 |
0.501 |
|
| 2005 |
Hoe HS, Wessner D, Beffert U, Becker AG, Matsuoka Y, Rebeck GW. F-spondin interaction with the apolipoprotein E receptor ApoEr2 affects processing of amyloid precursor protein. Molecular and Cellular Biology. 25: 9259-68. PMID 16227578 DOI: 10.1128/Mcb.25.21.9259-9268.2005 |
0.355 |
|
| 2005 |
Domnitz SB, Robbins EM, Hoang AW, Garcia-Alloza M, Hyman BT, Rebeck GW, Greenberg SM, Bacskai BJ, Frosch MP. Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 64: 588-94. PMID 16042310 DOI: 10.1097/01.Jnen.0000171644.00180.Fc |
0.532 |
|
| 2005 |
Hoe HS, Rebeck GW. Regulation of ApoE receptor proteolysis by ligand binding Molecular Brain Research. 137: 31-39. PMID 15950758 DOI: 10.1016/j.molbrainres.2005.02.013 |
0.349 |
|
| 2005 |
Martin-Rehrmann MD, Hoe HS, Capuani EM, Rebeck GW. Association of apolipoprotein J-positive β-amyloid plaques with dystrophic neurites in alzheimer's disease brain Neurotoxicity Research. 7: 231-241. PMID 15897157 DOI: 10.1007/BF03036452 |
0.455 |
|
| 2005 |
Hoe HS, Harris DC, Rebeck GW. Multiple pathways of apolipoprotein E signaling in primary neurons Journal of Neurochemistry. 93: 145-155. PMID 15773914 DOI: 10.1111/j.1471-4159.2004.03007.x |
0.406 |
|
| 2004 |
Ingelsson M, Jesneck J, Irizarry MC, Hyman BT, Rebeck GW. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease. Neuroscience Letters. 367: 228-31. PMID 15331159 DOI: 10.1016/J.Neulet.2004.06.011 |
0.581 |
|
| 2004 |
Irizarry MC, Deng A, Lleo A, Berezovska O, Von Arnim CA, Martin-Rehrmann M, Manelli A, LaDu MJ, Hyman BT, Rebeck GW. Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein. Journal of Neurochemistry. 90: 1132-43. PMID 15312168 DOI: 10.1111/J.1471-4159.2004.02581.X |
0.574 |
|
| 2004 |
Rebeck GW. Cholesterol efflux as a critical component of Alzheimer's disease pathogenesis. Journal of Molecular Neuroscience : Mn. 23: 219-224. PMID 15181250 DOI: 10.1385/Jmn:23:3:219 |
0.434 |
|
| 2004 |
Qiu Z, Hyman BT, Rebeck GW. Apolipoprotein E receptors mediate neurite outgrowth through activation of p44/42 mitogen-activated protein kinase in primary neurons. The Journal of Biological Chemistry. 279: 34948-56. PMID 15169786 DOI: 10.1074/Jbc.M401055200 |
0.49 |
|
| 2004 |
Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Annals of Neurology. 55: 250-6. PMID 14755729 DOI: 10.1002/Ana.10810 |
0.315 |
|
| 2004 |
Cooper MJ, Deng A, Rebeck GW. P1-215 Modulation of brain cholesterol metabolism by the liver X receptor: effects on Aβ levels Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80528-1 |
0.344 |
|
| 2004 |
Rebeck GW, Deng A, Hyman BT, Irizarry MC. O1-03-01 Apolipoprotein E inhibits gamma-secretase cleavage of the amyloid precursor protein Neurobiology of Aging. 25: S14. DOI: 10.1016/S0197-4580(04)80044-7 |
0.486 |
|
| 2003 |
Qiu Z, Crutcher KA, Hyman BT, Rebeck GW. ApoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience. 122: 291-303. PMID 14614897 DOI: 10.1016/J.Neuroscience.2003.08.017 |
0.397 |
|
| 2003 |
Fukumoto H, Ingelsson M, GÃ¥revik N, Wahlund LO, Nukina N, Yaguchi Y, Shibata M, Hyman BT, Rebeck GW, Irizarry MC. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis. Experimental Neurology. 183: 249-53. PMID 12957508 DOI: 10.1016/S0014-4886(03)00088-8 |
0.565 |
|
| 2003 |
Shin Y, Cho HS, Fukumoto H, Shimizu T, Shirasawa T, Greenberg SM, Rebeck GW. Aβ species, including IsoAsp23 Aβ, in Iowa-type familial cerebral amyloid angiopathy Acta Neuropathologica. 105: 252-258. PMID 12557012 DOI: 10.1007/S00401-002-0639-0 |
0.361 |
|
| 2002 |
Shin Y, Cho HS, Rebeck GW, Greenberg SM. Vascular changes in Iowa-type hereditary cerebral amyloid angiopathy Annals of the New York Academy of Sciences. 977: 245-251. PMID 12480757 DOI: 10.1111/J.1749-6632.2002.Tb04822.X |
0.316 |
|
| 2002 |
Fukumoto H, Deng A, Irizarry MC, Fitzgerald ML, Rebeck GW. Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Aβ levels Journal of Biological Chemistry. 277: 48508-48513. PMID 12384498 DOI: 10.1074/jbc.M209085200 |
0.426 |
|
| 2002 |
Guénette SY, Chang Y, Hyman BT, Tanzi RE, Rebeck GW. Low-density lipoprotein receptor-related protein levels and endocytic function are reduced by overexpression of the FE65 adaptor protein, FE65L1. Journal of Neurochemistry. 82: 755-62. PMID 12358780 DOI: 10.1046/J.1471-4159.2002.01009.X |
0.527 |
|
| 2002 |
Martin-Rehrmann MD, Hyun SC, Rebeck GW. Lack of association of two lipoprotein lipase polymorphisms with Alzheimer's disease Neuroscience Letters. 328: 109-112. PMID 12133567 DOI: 10.1016/S0304-3940(02)00511-6 |
0.439 |
|
| 2002 |
Arélin K, Kinoshita A, Whelan CM, Irizarry MC, Rebeck GW, Strickland DK, Hyman BT. LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes. Brain Research. Molecular Brain Research. 104: 38-46. PMID 12117549 DOI: 10.1016/S0169-328X(02)00203-6 |
0.617 |
|
| 2002 |
Qiu Z, Strickland DK, Hyman BT, Rebeck GW. alpha 2-Macroglobulin exposure reduces calcium responses to N-methyl-D-aspartate via low density lipoprotein receptor-related protein in cultured hippocampal neurons. The Journal of Biological Chemistry. 277: 14458-66. PMID 11839752 DOI: 10.1074/Jbc.M112066200 |
0.42 |
|
| 2001 |
Cataldo A, Rebeck GW, Ghetri B, Hulette C, Lippa C, Van Broeckhoven C, van Duijn C, Cras P, Bogdanovic N, Bird T, Peterhoff C, Nixon R. Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders. Annals of Neurology. 50: 661-5. PMID 11706973 DOI: 10.1002/Ana.1254 |
0.418 |
|
| 2001 |
Deng A, Irizarry MC, Nitsch RM, Growdon JH, Rebeck GW. Elevation of cystatin C in susceptible neurons in Alzheimer's disease. The American Journal of Pathology. 159: 1061-8. PMID 11549598 DOI: 10.1016/S0002-9440(10)61781-6 |
0.391 |
|
| 2001 |
Qiu Z, Naten DL, Liston JC, Yess J, Rebeck GW. A novel approach for studying endogenous Aβ processing using cultured primary neurons isolated from APP transgenic mice Experimental Neurology. 170: 186-194. PMID 11421596 DOI: 10.1006/exnr.2001.7703 |
0.406 |
|
| 2001 |
Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Annals of Neurology. 49: 697-705. PMID 11409420 DOI: 10.1002/Ana.1009 |
0.375 |
|
| 2001 |
Berezovska O, Jack C, Deng A, Gastineau N, Rebeck GW, Hyman BT. Notch1 and Amyloid Precursor Protein Are Competitive Substrates for Presenilin1-dependent γ-Secretase Cleavage Journal of Biological Chemistry. 276: 30018-30023. PMID 11408475 DOI: 10.1074/Jbc.M008268200 |
0.509 |
|
| 2001 |
Qiu Z, Strickland DK, Hyman BT, Rebeck GW. Elevation of LDL receptor-related protein levels via ligand interactions in alzheimer disease and in vitro Journal of Neuropathology and Experimental Neurology. 60: 430-440. PMID 11379818 DOI: 10.1093/Jnen/60.5.430 |
0.556 |
|
| 2001 |
Cho HS, Hyman BT, Greenberg SM, Rebeck GW. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Aβ aggregation Journal of Neuropathology and Experimental Neurology. 60: 342-349. PMID 11305869 DOI: 10.1093/Jnen/60.4.342 |
0.579 |
|
| 2001 |
Rebeck GW, Moir RD, Mui S, Strickland DK, Tanzi RE, Hyman BT. Association of membrane-bound amyloid precursor protein APP with the apolipoprotein E receptor LRP. Brain Research. Molecular Brain Research. 87: 238-45. PMID 11245926 DOI: 10.1016/S0169-328X(01)00006-7 |
0.5 |
|
| 2001 |
Kinoshita A, Whelan CM, Smith CJ, Mikhailenko I, Rebeck GW, Strickland DK, Hyman BT. Demonstration by Fluorescence Resonance Energy Transfer of Two Sites of Interaction between the Low-Density Lipoprotein Receptor-Related Protein and the Amyloid Precursor Protein: Role of the Intracellular Adapter Protein Fe65 The Journal of Neuroscience. 21: 8354-8361. DOI: 10.1523/Jneurosci.21-21-08354.2001 |
0.495 |
|
| 2000 |
Irizarry MC, Rebeck GW, Cheung B, Bales K, Paul SM, Holzman D, Hyman BT. Modulation of Aβ deposition in APP transgenic mice by an apolipoprotein E null background Annals of the New York Academy of Sciences. 920: 171-178. PMID 11193147 DOI: 10.1111/J.1749-6632.2000.Tb06919.X |
0.519 |
|
| 2000 |
Guénette SY, Bertram L, Crystal A, Bakondi B, Hyman BT, Rebeck GW, Tanzi RE, Blacker D. Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patients. Neuroscience Letters. 296: 17-20. PMID 11099823 DOI: 10.1016/S0304-3940(00)01607-4 |
0.483 |
|
| 2000 |
Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A, Zhang J, Müller-Thomsen T, Zuchowski K, Menzer G, Mann U, Papassotiropoulos A, Heun R, Zurdel J, Holst F, ... ... Rebeck GW, et al. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Archives of Neurology. 57: 1579-83. PMID 11074789 DOI: 10.1001/Archneur.57.11.1579 |
0.529 |
|
| 2000 |
Rebeck GW. Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease Neuroscience Letters. 293: 75-77. PMID 11065142 DOI: 10.1016/S0304-3940(00)01487-7 |
0.333 |
|
| 2000 |
Irizarry MC, Cheung BS, Rebeck GW, Paul SM, Bales KR, Hyman BT. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APP(V717F) transgenic mice Acta Neuropathologica. 100: 451-458. PMID 11045665 DOI: 10.1007/s004010000263 |
0.481 |
|
| 2000 |
Bacskai BJ, Xia MQ, Strickland DK, Rebeck GW, Hyman BT. The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors. Proceedings of the National Academy of Sciences of the United States of America. 97: 11551-6. PMID 11016955 DOI: 10.1073/Pnas.200238297 |
0.349 |
|
| 2000 |
Greenberg SM, Cho HS, O'Donnell HC, Rosand J, Segal AZ, Younkin LH, Younkin SG, Rebeck GW. Plasma beta-amyloid peptide, transforming growth factor-beta 1, and risk for cerebral amyloid angiopathy. Annals of the New York Academy of Sciences. 903: 144-9. PMID 10818500 DOI: 10.1111/J.1749-6632.2000.Tb06361.X |
0.322 |
|
| 2000 |
Hyman BT, Strickland D, Rebeck GW. Role of the low-density lipoprotein receptor-related protein in β- amyloid metabolism and Alzheimer disease Archives of Neurology. 57: 646-650. PMID 10815129 DOI: 10.1001/Archneur.57.5.646 |
0.524 |
|
| 2000 |
Ulery PG, Beers J, Mikhailenko I, Tanzi RE, Rebeck GW, Hyman BT, Strickland DK. Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. The Journal of Biological Chemistry. 275: 7410-5. PMID 10702315 DOI: 10.1074/Jbc.275.10.7410 |
0.48 |
|
| 2000 |
Guenette SY, Bakondi B, Crystal A, Hyman BT, Rebeck G, Blacker D, Tanzi RE. Genetic analysis of the FE65 intron 13 biallelic polymorphism in a family-based and a case control study Neurobiology of Aging. 21: 250. DOI: 10.1016/S0197-4580(00)83461-2 |
0.381 |
|
| 2000 |
Rebeck G, Ziu Z, Liston JC, Hyman BT. Clearance of endogenous soluble Aβ in neuronal and glial cultures Neurobiology of Aging. 21: 257. DOI: 10.1016/S0197-4580(00)83109-7 |
0.448 |
|
| 1999 |
Growdon WB, Cheung BS, Hyman BT, Rebeck GW. Lack of allelic imbalance in APOE ε3/4 brain mRNA expression in Alzheimer's disease Neuroscience Letters. 272: 83-86. PMID 10507547 DOI: 10.1016/S0304-3940(99)00557-1 |
0.555 |
|
| 1999 |
Rebeck GW, Cheung BS, Growdon WB, Deng A, Akuthota P, Locascio J, Greenberg SM, Hyman BT. Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease Neuroscience Letters. 272: 155-158. PMID 10505604 DOI: 10.1016/S0304-3940(99)00602-3 |
0.53 |
|
| 1999 |
Qiu Z, Strickland DK, Hyman BT, Rebeck GW. α2-Macroglobulin enhances the clearance of endogenous soluble β- amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons Journal of Neurochemistry. 73: 1393-1398. PMID 10501182 DOI: 10.1046/J.1471-4159.1999.0731393.X |
0.498 |
|
| 1999 |
Clatworthy AE, Stockinger W, Christie RH, Schneider WJ, Nimpf J, Hyman BT, Rebeck GW. Expression and alternate splicing of apolipoprotein E receptor 2 in brain. Neuroscience. 90: 903-11. PMID 10218790 DOI: 10.1016/S0306-4522(98)00489-8 |
0.436 |
|
| 1998 |
Hollenbach E, Ackermann S, Hyman BT, Rebeck GW. Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease Neurology. 50: 1905-1907. PMID 9633759 DOI: 10.1212/WNL.50.6.1905 |
0.472 |
|
| 1998 |
Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM. Progression of cerebral amyloid angiopathy: Accumulation of amyloid- β40 in affected vessels Journal of Neuropathology and Experimental Neurology. 57: 353-359. PMID 9600229 DOI: 10.1097/00005072-199804000-00008 |
0.458 |
|
| 1998 |
Greenberg SM, Vonsattel JPG, Segal AZ, Chiu RI, Clatworthy AE, Liao A, Hyman BT, Rebeck GW. Association of apolipoprotein E and ε2 vasculopathy in cerebral amyloid angiopathy Neurology. 50: 961-965. PMID 9566379 DOI: 10.1212/Wnl.50.4.961 |
0.309 |
|
| 1998 |
Rebeck GW, Alonzo NC, Berezovska O, Harr SD, Knowles RB, Growdon JH, Hyman BT, Mendez AJ. Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes. Experimental Neurology. 149: 175-82. PMID 9454626 DOI: 10.1006/Exnr.1997.6710 |
0.5 |
|
| 1997 |
Clatworthy AE, Gomez-Isla T, Rebeck GW, Wallace RB, Hyman BT. Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease Archives of Neurology. 54: 1289-1292. PMID 9341576 DOI: 10.1001/archneur.1997.00550220087019 |
0.522 |
|
| 1996 |
Hyman BT, Gomez-Isla T, Rebeck GW, Briggs M, Chung H, West HL, Greenberg S, Mui S, Nichols S, Wallace R, Growdon JH. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease. Annals of the New York Academy of Sciences. 802: 1-5. PMID 8993478 DOI: 10.1111/J.1749-6632.1996.Tb32592.X |
0.56 |
|
| 1996 |
Mui S, Briggs M, Chung H, Wallace RB, Gomez-Isla T, Rebeck GW, Hyman BT. A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the ε4 allele Neurology. 47: 196-201. PMID 8710077 DOI: 10.1212/Wnl.47.1.196 |
0.459 |
|
| 1996 |
Hyman BT, Hedley-Whyte ET, Rebeck GW, Vonsattel JP, West HL, Growdon JH. Apolipoprotein E epsilon4/4 in a neuropathologically normal very elderly individual. Archives of Neurology. 53: 215. PMID 8651872 DOI: 10.1001/Archneur.1996.00550030017010 |
0.545 |
|
| 1996 |
Chung H, Roberts CT, Greenberg S, Rebeck GW, Christie R, Wallace R, Jacob HJ, Hyman BT. Lack of association of trinucleotide repeat polymorphisms in very-low-density lipoprotein receptor gene with Alzheimer's disease. Annals of Neurology. 39: 800-3. PMID 8651653 DOI: 10.1002/Ana.410390617 |
0.53 |
|
| 1996 |
Hyman BT, Gomez-Isla T, West H, Briggs M, Chung H, Growdon JH, Rebeck GW. Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology. Annals of the New York Academy of Sciences. 777: 158-65. PMID 8624079 DOI: 10.1111/J.1749-6632.1996.Tb34414.X |
0.463 |
|
| 1996 |
Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Annals of Neurology. 39: 62-70. PMID 8572669 DOI: 10.1002/Ana.410390110 |
0.558 |
|
| 1995 |
Rebeck GW, Hyman BT. Apolipoprotein e--correction Neurology. 45: 598. PMID 7898732 DOI: 10.1212/WNL.45.3.598 |
0.334 |
|
| 1995 |
Hyman BT, West HL, Rebeck GW, Buldyrev SV, Mantegna RN, Ukleja M, Havlin S, Stanley HE. Quantitative analysis of senile plaques in Alzheimer disease: Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome) Proceedings of the National Academy of Sciences of the United States of America. 92: 3586-3590. PMID 7724603 DOI: 10.1073/Pnas.92.8.3586 |
0.48 |
|
| 1995 |
Nitsch RM, Rebeck GW, Deng M, Richardson UI, Tennis M, Schenk DB, Vigo-Pelfrey C, Lieberburg I, Wurtman RJ, Hyman BT. Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype. Annals of Neurology. 37: 512-8. PMID 7717688 DOI: 10.1002/Ana.410370414 |
0.562 |
|
| 1995 |
Hyman BT, West HL, Rebeck GW, Lai F, Mann DM. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Archives of Neurology. 52: 373-8. PMID 7710373 DOI: 10.1001/Archneur.1995.00540280059019 |
0.544 |
|
| 1995 |
Mui S, Rebeck GW, McKenna-Yasek D, Hyman BT, Brown RH. Apolipoprotein E ε4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis Annals of Neurology. 38: 460-463. PMID 7668834 DOI: 10.1002/Ana.410380318 |
0.474 |
|
| 1995 |
Greenberg SM, Rebeck GW, Vonsattel JPG, Gomez-Isla T, Hyman BT. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy Annals of Neurology. 38: 254-259. PMID 7654074 DOI: 10.1002/Ana.410380219 |
0.487 |
|
| 1995 |
Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argraves WS, Tanzi RE, Hyman BT, Strickland DK. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell. 82: 331-40. PMID 7543026 DOI: 10.1016/0092-8674(95)90320-8 |
0.573 |
|
| 1995 |
Rebeck GW, Harr SD, Strickland DK, Hyman BT. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein e receptor, the α2-macroglobulin receptor/low-density-lipoprotein receptor-related protein Annals of Neurology. 37: 211-217. PMID 7531418 DOI: 10.1002/Ana.410370212 |
0.531 |
|
| 1995 |
Gearing M, Schneider JA, Rebeck GW, Hyman BT, Mirra SS. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology. 45: 1985-90. PMID 7501146 DOI: 10.1212/Wnl.45.11.1985 |
0.441 |
|
| 1994 |
Poduri A, Gearing M, Rebeck GW, Mirra SS, Tigges J, Hyman BT. Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys. The American Journal of Pathology. 144: 1183-7. PMID 8203459 |
0.306 |
|
| 1994 |
Rebeck GW, Maynard KI, Hyman BT, Moskowitz MA. Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development. Proceedings of the National Academy of Sciences of the United States of America. 91: 3666-9. PMID 8170966 DOI: 10.1073/Pnas.91.9.3666 |
0.335 |
|
| 1994 |
Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoprotein ϵ4 allele frequency in the oldest old alzheimer’s patients and cognitively normal individuals Neurology. 44: 1513-1516. PMID 8058160 DOI: 10.1212/Wnl.44.8.1513 |
0.466 |
|
| 1994 |
West HL, Rebeck GW, Hyman BT. Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease. Neuroscience Letters. 175: 46-8. PMID 7970208 DOI: 10.1016/0304-3940(94)91074-X |
0.544 |
|
| 1994 |
Hyman BT, Strickland DK, Rebeck GW. α2-Macroglobulin receptor/low density lipoprotein receptor-related protein. Relationship to apolipoprotein E and role in Alzheimer disease senile plaques Annals of the New York Academy of Sciences. 737: 88-95. PMID 7944156 DOI: 10.1111/J.1749-6632.1994.Tb44303.X |
0.514 |
|
| 1994 |
Simonian NA, Rebeck GW, Hyman BT. Functional integrity of neural systems related to memory in Alzheimer's disease Progress in Brain Research. 100: 245-254. PMID 7938525 DOI: 10.1016/S0079-6123(08)60791-8 |
0.509 |
|
| 1993 |
Rebeck GW, Hyman BT. Neuroanatomical connections and specific regional vulnerability in Alzheimer's disease Neurobiology of Aging. 14: 45-47. PMID 8450931 DOI: 10.1016/0197-4580(93)90019-8 |
0.516 |
|
| 1993 |
Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 11: 575-80. PMID 8398148 DOI: 10.1016/0896-6273(93)90070-8 |
0.549 |
|
| 1993 |
Rebeck GW, Marzloff K, Hyman BT. The pattern of NADPH-diaphorase staining, a marker of nitric oxide synthase activity, is altered in the perforant pathway terminal zone in Alzheimer's disease Neuroscience Letters. 152: 165-168. PMID 7685863 DOI: 10.1016/0304-3940(93)90509-J |
0.51 |
|
| Show low-probability matches. |